Guanine-based  ||| S:0 E:14 ||| JJ
purines  ||| S:14 E:22 ||| NNS
modulate  ||| S:22 E:31 ||| VBP
the  ||| S:31 E:35 ||| DT
effect  ||| S:35 E:42 ||| NN
of  ||| S:42 E:45 ||| IN
L-NAME  ||| S:45 E:52 ||| JJ
on  ||| S:52 E:55 ||| IN
learning  ||| S:55 E:64 ||| VBG
and  ||| S:64 E:68 ||| CC
memory  ||| S:68 E:75 ||| NN
in  ||| S:75 E:78 ||| IN
rats  ||| S:78 E:83 ||| JJ
Guanosine  ||| S:83 E:93 ||| NNP
has  ||| S:93 E:97 ||| VBZ
been  ||| S:97 E:102 ||| VBN
reported  ||| S:102 E:111 ||| VBN
to  ||| S:111 E:114 ||| TO
exert  ||| S:114 E:120 ||| VB
neuroprotective  ||| S:120 E:136 ||| JJ
effects ||| S:136 E:143 ||| NNS
.  ||| S:143 E:145 ||| .
We  ||| S:145 E:148 ||| PRP
recently  ||| S:148 E:157 ||| RB
reported  ||| S:157 E:166 ||| VBN
that ||| S:166 E:170 ||| IN
,  ||| S:170 E:172 ||| ,
following  ||| S:172 E:182 ||| VBG
intraperitoneal  ||| S:182 E:198 ||| NNS
( ||| S:198 E:199 ||| -LRB-
i.p. ||| S:199 E:203 ||| NNP
)  ||| S:203 E:205 ||| -RRB-
injection  ||| S:205 E:215 ||| NN
to  ||| S:215 E:218 ||| TO
rats ||| S:218 E:222 ||| NNS
,  ||| S:222 E:224 ||| ,
it  ||| S:224 E:227 ||| PRP
resulted  ||| S:227 E:236 ||| VBD
to  ||| S:236 E:239 ||| TO
be  ||| S:239 E:242 ||| VB
widely  ||| S:242 E:249 ||| RB
distributed ||| S:249 E:260 ||| VBN
.  ||| S:260 E:262 ||| .
Its  ||| S:262 E:266 ||| PRP$
metabolic  ||| S:266 E:276 ||| JJ
product  ||| S:276 E:284 ||| NN
guanine  ||| S:284 E:292 ||| VBZ
also  ||| S:292 E:297 ||| RB
rapidly  ||| S:297 E:305 ||| RB
increased  ||| S:305 E:315 ||| VBN
in  ||| S:315 E:318 ||| IN
all  ||| S:318 E:322 ||| PDT
the  ||| S:322 E:326 ||| DT
tissues ||| S:326 E:333 ||| NNS
,  ||| S:333 E:335 ||| ,
including  ||| S:335 E:345 ||| VBG
brain ||| S:345 E:350 ||| NN
,  ||| S:350 E:352 ||| ,
after  ||| S:352 E:358 ||| IN
i.p.  ||| S:358 E:363 ||| CD
injection  ||| S:363 E:373 ||| NN
of  ||| S:373 E:376 ||| IN
guanosine  ||| S:376 E:386 ||| NN
and  ||| S:386 E:390 ||| CC
consistently  ||| S:390 E:403 ||| RB
we  ||| S:403 E:406 ||| PRP
found  ||| S:406 E:412 ||| VBD
a  ||| S:412 E:414 ||| DT
significant  ||| S:414 E:426 ||| JJ
enzymatic  ||| S:426 E:436 ||| JJ
activity  ||| S:436 E:445 ||| NN
of  ||| S:445 E:448 ||| IN
a  ||| S:448 E:450 ||| DT
soluble  ||| S:450 E:458 ||| JJ
purine  ||| S:458 E:465 ||| JJ
nucleoside  ||| S:465 E:476 ||| JJ
phosphorylase  ||| S:476 E:490 ||| NN
in  ||| S:490 E:493 ||| IN
the  ||| S:493 E:497 ||| DT
plasma  ||| S:497 E:504 ||| NN
of  ||| S:504 E:507 ||| IN
the  ||| S:507 E:511 ||| DT
treated  ||| S:511 E:519 ||| JJ
animals ||| S:519 E:526 ||| NNS
.  ||| S:526 E:528 ||| .
In  ||| S:528 E:531 ||| IN
this  ||| S:531 E:536 ||| DT
study  ||| S:536 E:542 ||| NN
the  ||| S:542 E:546 ||| DT
effect  ||| S:546 E:553 ||| NN
of  ||| S:553 E:556 ||| IN
per  ||| S:556 E:560 ||| IN
os  ||| S:560 E:563 ||| JJ
administration  ||| S:563 E:578 ||| NN
of  ||| S:578 E:581 ||| IN
guanosine  ||| S:581 E:591 ||| NN
or  ||| S:591 E:594 ||| CC
guanine  ||| S:594 E:602 ||| JJ
to  ||| S:602 E:605 ||| TO
rats  ||| S:605 E:610 ||| VB
submitted  ||| S:610 E:620 ||| VBN
to  ||| S:620 E:623 ||| TO
passive  ||| S:623 E:631 ||| JJ
avoidance  ||| S:631 E:641 ||| NN
task  ||| S:641 E:646 ||| NN
has  ||| S:646 E:650 ||| VBZ
been  ||| S:650 E:655 ||| VBN
evaluated ||| S:655 E:664 ||| VBN
.  ||| S:664 E:666 ||| .
Guanosine  ||| S:666 E:676 ||| NNP
( ||| S:676 E:677 ||| -LRB-
4  ||| S:677 E:679 ||| CD
and  ||| S:679 E:683 ||| CC
8  ||| S:683 E:685 ||| CD
mg ||| S:685 E:687 ||| CD
/ ||| S:687 E:688 ||| CD
kg ||| S:688 E:690 ||| CD
)  ||| S:690 E:692 ||| -RRB-
administered  ||| S:692 E:705 ||| FW
pretraining  ||| S:705 E:717 ||| FW
impaired  ||| S:717 E:726 ||| FW
retention  ||| S:726 E:736 ||| FW
in  ||| S:736 E:739 ||| IN
the  ||| S:739 E:743 ||| DT
passive  ||| S:743 E:751 ||| JJ
avoidance  ||| S:751 E:761 ||| NN
task  ||| S:761 E:766 ||| NN
and  ||| S:766 E:770 ||| CC
was  ||| S:770 E:774 ||| VBD
unable  ||| S:774 E:781 ||| JJ
to  ||| S:781 E:784 ||| TO
prevent  ||| S:784 E:792 ||| VB
the  ||| S:792 E:796 ||| DT
amnesic  ||| S:796 E:804 ||| JJ
effect  ||| S:804 E:811 ||| NN
caused  ||| S:811 E:818 ||| VBN
by  ||| S:818 E:821 ||| IN
100  ||| S:821 E:825 ||| CD
mg ||| S:825 E:827 ||| FW
/ ||| S:827 E:828 ||| FW
kg  ||| S:828 E:831 ||| FW
N-omega-nitro-l-arginine  ||| S:831 E:856 ||| FW
methyl  ||| S:856 E:863 ||| FW
ester  ||| S:863 E:869 ||| FW
( ||| S:869 E:870 ||| -LRB-
L-NAME ||| S:870 E:876 ||| NNP
) ||| S:876 E:877 ||| -RRB-
,  ||| S:877 E:879 ||| ,
an  ||| S:879 E:882 ||| DT
inhibitor  ||| S:882 E:892 ||| NN
of  ||| S:892 E:895 ||| IN
the  ||| S:895 E:899 ||| DT
nitric  ||| S:899 E:906 ||| JJ
oxide  ||| S:906 E:912 ||| NN
synthase  ||| S:912 E:921 ||| NNS
( ||| S:921 E:922 ||| -LRB-
NOS ||| S:922 E:925 ||| NNP
)  ||| S:925 E:927 ||| -RRB-
known  ||| S:927 E:933 ||| VBN
to  ||| S:933 E:936 ||| TO
reduce  ||| S:936 E:943 ||| VB
the  ||| S:943 E:947 ||| DT
capability  ||| S:947 E:958 ||| NN
of  ||| S:958 E:961 ||| IN
treated  ||| S:961 E:969 ||| JJ
animals  ||| S:969 E:977 ||| NNS
to  ||| S:977 E:980 ||| TO
acquire  ||| S:980 E:988 ||| VB
or  ||| S:988 E:991 ||| CC
retain  ||| S:991 E:998 ||| VB
informations  ||| S:998 E:1011 ||| VBN
in  ||| S:1011 E:1014 ||| IN
several  ||| S:1014 E:1022 ||| JJ
learning  ||| S:1022 E:1031 ||| NN
tasks ||| S:1031 E:1036 ||| NNS
.  ||| S:1036 E:1038 ||| .
On  ||| S:1038 E:1041 ||| IN
the  ||| S:1041 E:1045 ||| DT
contrary ||| S:1045 E:1053 ||| NN
,  ||| S:1053 E:1055 ||| ,
guanine  ||| S:1055 E:1063 ||| NNS
( ||| S:1063 E:1064 ||| -LRB-
4  ||| S:1064 E:1066 ||| CD
and  ||| S:1066 E:1070 ||| CC
8  ||| S:1070 E:1072 ||| CD
mg ||| S:1072 E:1074 ||| CD
/ ||| S:1074 E:1075 ||| CD
kg ||| S:1075 E:1077 ||| CD
) ||| S:1077 E:1078 ||| -RRB-
,  ||| S:1078 E:1080 ||| ,
which  ||| S:1080 E:1086 ||| WDT
per  ||| S:1086 E:1090 ||| IN
se  ||| S:1090 E:1093 ||| NN
did  ||| S:1093 E:1097 ||| VBD
not  ||| S:1097 E:1101 ||| RB
modify  ||| S:1101 E:1108 ||| VB
the  ||| S:1108 E:1112 ||| DT
latency  ||| S:1112 E:1120 ||| NN
to  ||| S:1120 E:1123 ||| TO
step-trough  ||| S:1123 E:1135 ||| JJ
in  ||| S:1135 E:1138 ||| IN
the  ||| S:1138 E:1142 ||| DT
passive  ||| S:1142 E:1150 ||| JJ
avoidance  ||| S:1150 E:1160 ||| NN
task ||| S:1160 E:1164 ||| NN
,  ||| S:1164 E:1166 ||| ,
when  ||| S:1166 E:1171 ||| WRB
administered  ||| S:1171 E:1184 ||| VBN
pretraining  ||| S:1184 E:1196 ||| CD
15  ||| S:1196 E:1199 ||| CD
min  ||| S:1199 E:1203 ||| NN
before  ||| S:1203 E:1210 ||| IN
L-NAME  ||| S:1210 E:1217 ||| JJ
prevented ||| S:1217 E:1226 ||| NN
,  ||| S:1226 E:1228 ||| ,
in  ||| S:1228 E:1231 ||| IN
a  ||| S:1231 E:1233 ||| DT
dose  ||| S:1233 E:1238 ||| JJ
dependent  ||| S:1238 E:1248 ||| JJ
manner ||| S:1248 E:1254 ||| NN
,  ||| S:1254 E:1256 ||| ,
the  ||| S:1256 E:1260 ||| DT
amnesic  ||| S:1260 E:1268 ||| JJ
effect  ||| S:1268 E:1275 ||| NN
of  ||| S:1275 E:1278 ||| IN
the  ||| S:1278 E:1282 ||| DT
NOS  ||| S:1282 E:1286 ||| NNP
inhibitor ||| S:1286 E:1295 ||| NN
.  ||| S:1295 E:1297 ||| .
Moreover  ||| S:1297 E:1306 ||| RB
the  ||| S:1306 E:1310 ||| DT
nucleobase  ||| S:1310 E:1321 ||| NN
was  ||| S:1321 E:1325 ||| VBD
able  ||| S:1325 E:1330 ||| JJ
to  ||| S:1330 E:1333 ||| TO
rescue  ||| S:1333 E:1340 ||| VB
the  ||| S:1340 E:1344 ||| DT
memory  ||| S:1344 E:1351 ||| NN
trace  ||| S:1351 E:1357 ||| VBZ
also  ||| S:1357 E:1362 ||| RB
when  ||| S:1362 E:1367 ||| WRB
administered  ||| S:1367 E:1380 ||| VBN
after  ||| S:1380 E:1386 ||| IN
training ||| S:1386 E:1394 ||| NN
.  ||| S:1394 E:1396 ||| .
Neither  ||| S:1396 E:1404 ||| DT
guanosine  ||| S:1404 E:1414 ||| NN
nor  ||| S:1414 E:1418 ||| CC
guanine  ||| S:1418 E:1426 ||| NNS
had  ||| S:1426 E:1430 ||| VBD
effects  ||| S:1430 E:1438 ||| NNS
on  ||| S:1438 E:1441 ||| IN
locomotor  ||| S:1441 E:1451 ||| JJ
activity ||| S:1451 E:1459 ||| NN
.  ||| S:1459 E:1461 ||| .
These  ||| S:1461 E:1467 ||| DT
results  ||| S:1467 E:1475 ||| NNS
indicate  ||| S:1475 E:1484 ||| VBP
that  ||| S:1484 E:1489 ||| DT
guanine  ||| S:1489 E:1497 ||| NN
can  ||| S:1497 E:1501 ||| MD
exert  ||| S:1501 E:1507 ||| VB
important  ||| S:1507 E:1517 ||| JJ
biological  ||| S:1517 E:1528 ||| JJ
activities  ||| S:1528 E:1539 ||| NNS
which  ||| S:1539 E:1545 ||| WDT
may  ||| S:1545 E:1549 ||| MD
be  ||| S:1549 E:1552 ||| VB
different  ||| S:1552 E:1562 ||| JJ
from  ||| S:1562 E:1567 ||| IN
those  ||| S:1567 E:1573 ||| DT
mediated  ||| S:1573 E:1582 ||| NN
by  ||| S:1582 E:1585 ||| IN
its  ||| S:1585 E:1589 ||| PRP$
precursor  ||| S:1589 E:1599 ||| JJ
guanosine ||| S:1599 E:1608 ||| NN
,  ||| S:1608 E:1610 ||| ,
thus  ||| S:1610 E:1615 ||| RB
this  ||| S:1615 E:1620 ||| DT
evenience  ||| S:1620 E:1630 ||| NN
should  ||| S:1630 E:1637 ||| MD
be  ||| S:1637 E:1640 ||| VB
taken  ||| S:1640 E:1646 ||| VBN
into  ||| S:1646 E:1651 ||| IN
account  ||| S:1651 E:1659 ||| NN
when  ||| S:1659 E:1664 ||| WRB
the  ||| S:1664 E:1668 ||| DT
biological  ||| S:1668 E:1679 ||| JJ
effects  ||| S:1679 E:1687 ||| NNS
of  ||| S:1687 E:1690 ||| IN
guanosine  ||| S:1690 E:1700 ||| NNS
are  ||| S:1700 E:1704 ||| VBP
evaluated ||| S:1704 E:1713 ||| VBN
.  ||| S:1713 E:1715 ||| .
